17 results on '"Fernández-Puntero, B."'
Search Results
2. Is minimising waste volume for drawing blood samples in critically ill patients feasible?
- Author
-
Castro-Olmo, F.J., Morales-Fernández, P., Alcaide-Martín, M.J., Fernández-Puntero, B., Quintana-Díaz, M., and Aceña-Gil, V.
- Published
- 2023
- Full Text
- View/download PDF
3. Monitoring magnesium status in the pediatric liver transplant: Total or ionized?
- Author
-
Martínez-Chávez, E., primary, Sufrate Vergara, B., additional, Ramírez-Amoros, C., additional, Pizarro Sánchez, C., additional, Hernández Oliveros, F., additional, Sanabria Carretero, P., additional, Rodríguez Pérez, E., additional, Reinoso-Barbero, F., additional, Acolea Domingo, N., additional, Losantos-García, I., additional, Buño Soto, A., additional, Alcaide Martin, M.J., additional, and Fernández-Puntero, B., additional
- Published
- 2024
- Full Text
- View/download PDF
4. Differences in sodium and glucose results between POCT and central laboratory and influencing factors in clinical practice
- Author
-
Balbás, L.A. Bautista, primary, Sáez, P. Oliver, additional, Fernández-Calle, P., additional, Alcaide, M.J., additional, Fernández-Puntero, B., additional, and Buño, A., additional
- Published
- 2019
- Full Text
- View/download PDF
5. Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study.
- Author
-
Cornejo del Río, V., Mostaza, J., Lahoz, C., Sánchez-Arroyo, V., Sabín, C., López, S., Patrón, P., Fernández-García, P., Fernández-Puntero, B., Vicent, D., Montesano-Sánchez, L., García-Iglesias, F., González-Alegre, T., Estirado, E., Laguna, F., de Burgos-Lunar, C., Gómez-Campelo, P., Abanades-Herranz, J. C., de Miguel-Yanes, J. M., and Salinero-Fort, M. A.
- Subjects
TYPE 2 diabetes diagnosis ,DISEASE prevalence ,CROSS-sectional method ,URIC acid ,LIPIDS - Abstract
Aim: To describe the prevalence of Peripheral Artery Disease (PAD) in a random population sample and to evaluate its relationship with Mediterranean diet and with other potential cardiovascular risk factors such as serum uric acid and pulse pressure in individuals ranged 45 to 74 years. Methods: Cross-sectional analysis of 1568 subjects (mean age 6.5 years, 43% males), randomly selected from the population. A fasting blood sample was obtained to determine glucose, lipids, and HbA1C levels. An oral glucose tolerance test was performed in non-diabetic subjects. PAD was evaluated by ankle–brachial index and/or having a prior diagnosis. Results: PAD prevalence was 3.81% (95% CI, 2.97–4.87) for all participants. In men, PAD prevalence was significantly higher than in women [5.17% (95% CI, 3.74–7.11) vs. 2.78% (95% CI, 1.89–4.07); p = 0.014]. Serum uric acid in the upper quartile was associated with the highest odds ratio (OR) of PAD (for uric acid > 6.1 mg/dl, OR = 4.31; 95% CI, 1.49–12.44). The remaining variables more strongly associated with PAD were: Heart rate >90 bpm (OR = 4.16; 95%CI, 1.62–10.65), pulse pressure in the upper quartile (≥ 54 mmHg) (OR = 3.82; 95%CI, 1.50–9.71), adherence to Mediterranean diet (OR = 2.73; 95% CI, 1.48–5.04), and former smoker status (OR = 2.04; 95%CI, 1.00–4.16). Conclusions: Our results show the existence of a low prevalence of peripheral artery disease in a population aged 45–74 years. Serum uric acid, pulse pressure and heart rate >90 bpm were strongly associated with peripheral artery disease. The direct association between Mediterranean diet and peripheral artery disease that we have found should be evaluated through a follow-up study under clinical practice conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
- Author
-
Salinero-Fort, M. A., Burgos-Lunar, C., Lahoz, C., Mostaza, J. M., Abánades-Herranz, J. C., Laguna-Cuesta, F., Estirado-de Cabo, E., García-Iglesias, F., González-Alegre, T., Fernández-Puntero, B., Montesano-Sánchez, L., Vicent-López, D., Cornejo-del Río, V., Fernández-García, P. J., Sánchez-Arroyo, V., Sabín-Rodríguez, C., López-López, S., Patrón-Barandio, P., Gómez-Campelo, P., and null, null
- Subjects
DIABETES risk factors ,RECEIVER operating characteristic curves ,GLUCOSE ,FASTING ,CROSS-sectional method - Abstract
Aim: To evaluate the performance of the Finnish Diabetes Risk Score (FINDRISC) and a simplified FINDRISC score (MADRISC) in screening for undiagnosed type 2 diabetes mellitus (UT2DM) and dysglycaemia. Methods: A population-based, cross-sectional, descriptive study was carried out with participants with UT2DM, ranged between 45–74 years and lived in two districts in the north of metropolitan Madrid (Spain). The FINDRISC and MADRISC scores were evaluated using the area under the receiver operating characteristic curve method (ROC-AUC). Four different gold standards were used for UT2DM and any dysglycaemia, as follows: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), HbA1c, and OGTT or HbA1c. Dysglycaemia and UT2DM were defined according to American Diabetes Association criteria. Results: The study population comprised 1,426 participants (832 females and 594 males) with a mean age of 62 years (SD = 6.1). When HbA1c or OGTT criteria were used, the prevalence of UT2DM was 7.4% (10.4% in men and 5.2% in women; p<0.01) and the FINDRISC ROC-AUC for UT2DM was 0.72 (95% CI, 0.69–0.74). The optimal cut-off point was ≥13 (sensitivity = 63.8%, specificity = 65.1%). The ROC-AUC of MADRISC was 0.76 (95% CI, 0.72–0.81) with ≥13 as the optimal cut-off point (sensitivity = 84.8%, specificity = 54.6%). FINDRISC score ≥12 for detecting any dysglycaemia offered the best cut-off point when HbA1c alone or OGTT and HbA1c were the criteria used. Conclusions: FINDRISC proved to be a useful instrument in screening for dysglycaemia and UT2DM. In the screening of UT2DM, the simplified MADRISC performed as well as FINDRISC. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Trisomía parcial 1q por translocación materna
- Author
-
Campos Tristán, C., primary and Fernández Puntero, B., additional
- Published
- 2000
- Full Text
- View/download PDF
8. Influence of fraxetin on the lifespan and longevity facing induced stress
- Author
-
Dolz, I. Barroso, primary, Fernández‐Puntero, B., additional, Benedí, J., additional, Iglesias, I., additional, and del Fresno, A. Villar, additional
- Published
- 1998
- Full Text
- View/download PDF
9. Fraxetin in the ageing of Drosophila melongaster
- Author
-
Barroso Dolz, I., Fernández Puntero, B., Juana Benedi, Iglesias Peinado, I., and Villar Del Fresno, A.
10. Usefulness of mid-regional proadrenomedullin levels in the resuscitation phase of severely burned patients and its utility in early sepsis detection.
- Author
-
Flores E, Estébanez B, Quintana M, Fernández-Puntero B, Nanwani K, Cachafeiro L, Martínez JR, Agrifoglio A, and Sánchez-Sánchez M
- Subjects
- Humans, Middle Aged, Male, Female, Prospective Studies, Adult, Aged, Hemodynamics physiology, Lactic Acid blood, Early Diagnosis, Thermodilution methods, Peptide Fragments, Burns blood, Burns complications, Adrenomedullin blood, Sepsis blood, Sepsis diagnosis, Biomarkers blood, Protein Precursors blood, Resuscitation methods, Procalcitonin blood, C-Reactive Protein metabolism
- Abstract
Introduction: Mid-regional proadrenomedullin (MR-proADM) reflects the adrenomedullin level, which has vasodilatory activity, decreases endothelial permeability, and downregulates proinflammatory cytokines. Sepsis diagnosis in these patients is difficult, and MR-proADM is a widely studied sepsis biomarker. This study evaluates MR-proADM levels during the resuscitation phase, considering the potential influence of haemodynamic changes and its usefulness for the early sepsis detection in burn patients., Methods: A prospective observational study performed in the Critical Burn Unit. Demographic data, burn characteristics, comorbidities, prognostic/severity scales, and haemodynamic parameters were collected. The resuscitation protocol guided by diuresis, transpulmonary thermodilution, and lactate levels was followed. Blood samples were collected at various time points for biomarker measurement. Biomarker levels, including MR-proADM, C-reactive protein, and procalcitonin were measured during the resuscitation phase and septic episodes., Results: Twenty-seven patients were included, with a mean age of 51 years, a mean total body surface area burn of 41.8%, a mean Abbreviated Burn Severity Index of 9.7, and a mean Baux score of 92. MR-proADM levels were elevated on admission (0.9 ± 0.5 nmol/l) and continued to increase slightly during the resuscitation phase (2.4 ± 2.2 nmol/l). Haemodynamic changes during resuscitation did not significantly affect MR-proADM levels. Twelve of the 27 patients developed sepsis, whose MR-proADM levels were significantly elevated on the day of clinical diagnosis (3.91 ± 2.99 nmol/l) and even the day before (2.57 ± 3.37). Higher MR-proADM levels were associated with greater severity as measured by the Sequential Organ Failure Assessment score. The mean MR-proadrenomedullin values during resuscitation in the patients who died was 3.51 ± 2.30 nmol/l, whereas in the survivors it was 1.28 ± 1.10 nmol/l (p = 0.0001)., Conclusion: MR-proadrenomedullin values are elevated after thermal injury but are not affected by haemodynamic changes. During septic episodes in burn patients, MR-proADM rises early (the day before sepsis diagnosis). Higher levels of MR-proADM are associated with greater organ dysfunction and mortality., (Copyright © 2024 Elsevier Ltd and International Society of Burns Injuries. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. Laboratory interpretative comments and guidance: clinical and operative outcomes on moderate to severe hyponatraemia patient management.
- Author
-
Montero-San-Martín B, Oliver P, Fernandez-Calle P, Sánchez-Pascuala Callau JJ, Díaz Almirón M, Alcaide Martín MJ, Fernández-Puntero B, Duque Alcorta M, Valero Recio JM, Martín Quirós A, de Ceano-Vivas la Calle M, Martín Sánchez J, Rivas Becerra B, Vega Cabrera C, Melgosa Hijosa M, and Buno Soto A
- Subjects
- Adult, Child, Humans, Laboratories, Retrospective Studies, Sodium, Hyponatremia diagnosis, Hyponatremia therapy
- Abstract
Aims: Hyponatraemia is the most common body fluid disorders but often goes unnoticed. Our laboratory incorporated a standardised procedure to help clinicians detect moderate/severe hyponatraemia. The study aims were to evaluate the outcomes on patient care and clinicians' satisfaction., Methods: The study, observational and retrospective, included 1839 cases, adult and paediatric patients, with sodium concentration <130 mmol/L. The procedure consisted of interpretative comments in the emergency and core laboratories report and the point-of-care testing blood gas network report. We evaluated hyponatraemia length in two equal periods: before and after the implementation. We conducted a survey addressed to the staff of the clinical settings involved to know their satisfaction., Results: The median hyponatraemia length decreased significantly from 4.95 hours (2.08-16.57) in the first period to 2.17 hours (1.06-5.39) in the second period. The lack of hyponatraemia patients follow-up was significantly less after the procedure implementation. The survey was answered by 92 (60 senior specialists and 32 residents) out of 110 clinicians surveyed. Ninety of them (98%) answered positively., Conclusions: We have demonstrated the reduction in the time for diagnosing and management by physicians, the higher uniformity in the time required to solve hyponatraemia episodes following our laboratory procedure and the clinicians' satisfaction., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
12. ANN-Based Discernment of Septic and Inflammatory Synovial Fluid: A Novel Method Using Viscosity Data from a QCR Sensor.
- Author
-
Miranda-Martínez A, Sufrate-Vergara B, Fernández-Puntero B, Alcaide-Martin MJ, Buño-Soto A, and Serrano-Olmedo JJ
- Subjects
- Viscosity, Synovial Fluid chemistry
- Abstract
The synovial fluid (SF) analysis involves a series of chemical and physical studies that allow opportune diagnosing of septic, inflammatory, non-inflammatory, and other pathologies in joints. Among the variety of analyses to be performed on the synovial fluid, the study of viscosity can help distinguish between these conditions, since this property is affected in pathological cases. The problem with viscosity measurement is that it usually requires a large sample volume, or the necessary instrumentation is bulky and expensive. This study compares the viscosity of normal synovial fluid samples with samples with infectious and inflammatory pathologies and classifies them using an ANN (Artificial Neural Network). For this purpose, a low-cost, portable QCR-based sensor (10 MHz) was used to measure the viscous responses of the samples by obtaining three parameters: Δf, ΔΓ (parameters associated with the viscoelastic properties of the fluid), and viscosity calculation. These values were used to train the algorithm. Different versions of the ANN were compared, along with other models, such as SVM and random forest. Thirty-three samples of SF were analyzed. Our study suggests that the viscosity characterized by our sensor can help distinguish infectious synovial fluid, and that implementation of ANN improves the accuracy of synovial fluid classification.
- Published
- 2022
- Full Text
- View/download PDF
13. Peripheral Atherosclerosis in Patients With Erectile Dysfunction: A Population-Based Study.
- Author
-
Lahoz C, Mostaza JM, Salinero-Fort MA, García-Iglesias F, González-Alegre T, Estirado E, Laguna F, de Burgos-Lunar C, Sánchez-Arroyo V, Sabín C, López S, Cornejo-Del-Río V, Patrón P, Fernández-García P, Fernández-Puntero B, Vicent D, and Montesano-Sanchez L
- Subjects
- Aged, Ankle Brachial Index, Atherosclerosis complications, Atherosclerosis physiopathology, Carotid Intima-Media Thickness, Cross-Sectional Studies, Erectile Dysfunction etiology, Erectile Dysfunction physiopathology, Humans, Male, Middle Aged, Prevalence, Risk Factors, Atherosclerosis pathology, Carotid Arteries pathology, Erectile Dysfunction pathology, Lower Extremity pathology
- Abstract
Introduction: The presence of erectile dysfunction (ED) could be a warning of vascular disease in different arterial territories., Aim: The aim of this study was to investigate the association between ED and the presence of atherosclerosis in 2 different vascular beds: carotid and lower limbs., Methods: A total of 614 volunteers between 45 and 74 years of age (mean age 61.0 years) were randomly selected from the general population. ED was assessed using the International Index of Erectile Function (IIEF-5). Ankle-brachial index (ABI) measurement and carotid atherosclerosis were evaluated by echo-Doppler., Main Outcome Measures: Mean carotid intima-media thickness (IMT), prevalence of carotid plaques, mean ABI, and prevalence of ABI < 0.9 were the main outcome measures., Results: ED was present in 373 subjects (59.7%). Mean carotid IMT was significantly higher in men with ED (0.762 ± 0.151 mm vs 0.718 ± 0.114 mm, P < .001). Also the global prevalence of carotid plaques was more frequent in men with ED (63.8% vs 44.8%, P < .001), even after adjusting by age, cardiovascular risk factors, and ongoing treatment (P = .039). Both the IMT and the prevalence of carotid plaques increased significantly with ED severity (P trend .004 and <.001, respectively). There were no significant differences between groups neither in mean ABI nor in the prevalence of subjects with ABI < 0.9. However, there was a trend to a lower ABI and a higher prevalence of ABI < 0.9 with increasing ED severity., Conclusion: In the general population, the presence of ED identifies subjects with higher atherosclerosis burden in carotid arteries but not in the lower extremities., (Copyright © 2016 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
14. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
- Author
-
Salinero-Fort MÁ, de Burgos-Lunar C, Mostaza Prieto J, Lahoz Rallo C, Abánades-Herranz JC, Gómez-Campelo P, Laguna Cuesta F, Estirado De Cabo E, García Iglesias F, González Alegre T, Fernández Puntero B, Montesano Sánchez L, Vicent López D, Cornejo Del Río V, Fernández García PJ, Sabín Rodríguez C, López López S, and Patrón Barandío P
- Subjects
- Aged, Bias, Female, Humans, Logistic Models, Male, Mass Screening, Middle Aged, Prospective Studies, ROC Curve, Risk Factors, Spain epidemiology, Blood Glucose analysis, Diabetes Mellitus, Type 2 diagnosis, Diabetes Mellitus, Type 2 epidemiology, Early Diagnosis, Glucose Tolerance Test methods, Prediabetic State diagnosis
- Abstract
Introduction: The incidence of type 2 diabetes mellitus (T2DM) is increasing worldwide. When diagnosed, many patients already have organ damage or advance subclinical atherosclerosis. An early diagnosis could allow the implementation of lifestyle changes and treatment options aimed at delaying the progression of the disease and to avoid cardiovascular complications. Different scores for identifying undiagnosed diabetes have been reported, however, their performance in populations of southern Europe has not been sufficiently evaluated. The main objectives of our study are: to evaluate the screening performance and cut-off points of the main scores that identify the risk of undiagnosed T2DM and prediabetes in a Spanish population, and to develop and validate our own predictive models of undiagnosed T2DM (screening model), and future T2DM (prediction risk model) after 5-year follow-up. As a secondary objective, we will evaluate the atherosclerotic burden of the population with undiagnosed T2DM., Methods and Analysis: Population-based prospective cohort study with baseline screening, to evaluate the performance of the FINDRISC, DANISH, DESIR, ARIC and QDScore, against the gold standard tests: Fasting plasma glucose, oral glucose tolerance and/or HbA1c. The sample size will include 1352 participants between the ages of 45 and 74 years., Analysis: sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio positive, likelihood ratio negative and receiver operating characteristic curves and area under curve. Binary logistic regression for the first 700 individuals (derivation) and last 652 (validation) will be performed. All analyses will be calculated with their 95% CI; statistical significance will be p<0.05., Ethics and Dissemination: The study protocol has been approved by the Research Ethics Committee of the Carlos III Hospital (Madrid). The score performance and predictive model will be presented in medical conferences, workshops, seminars and round table discussions. Furthermore, the predictive model will be published in a peer-reviewed medical journal to further increase the exposure of the scores., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.)
- Published
- 2015
- Full Text
- View/download PDF
15. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain.
- Author
-
Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, de la Calle F, Borobia AM, Sánchez-Seco P, Lago M, Figueira JC, Fernández-Puntero B, Viejo A, Negredo A, Nuñez C, Flores E, Carcas AJ, Jiménez-Yuste V, Lasala F, García-de-Lorenzo A, Arnalich F, and Arribas JR
- Subjects
- Acute Lung Injury etiology, Adult, Amides therapeutic use, Antiviral Agents therapeutic use, Female, Humans, Occupational Diseases therapy, Patient Isolation, Pyrazines therapeutic use, Respiratory Distress Syndrome therapy, Spain, Superinfection etiology, Transfusion Reaction, Viral Load, Hemorrhagic Fever, Ebola therapy, Nursing Assistants, Occupational Diseases etiology, Plasma, Respiratory Distress Syndrome etiology
- Abstract
Background: In the current epidemic of Ebola virus disease, health-care workers have been transferred to Europe and the USA for optimised supportive care and experimental treatments. We describe the clinical course of the first case of Ebola virus disease contracted outside of Africa, in Madrid, Spain., Methods: Herein we report clinical, laboratory, and virological findings of the treatment of a female nurse assistant aged 44 years who was infected with Ebola virus around Sept 25-26, 2014, while caring for a Spanish missionary with confirmed Ebola virus disease who had been medically evacuated from Sierra Leone to La Paz-Carlos III University Hospital, Madrid. We also describe the use of experimental treatments for Ebola virus disease in this patient., Findings: The patient was symptomatic for 1 week before first hospital admission on Oct 6, 2014. We used supportive treatment with intravenous fluids, broad-spectrum antibiotics, and experimental treatments with convalescent plasma from two survivors of Ebola virus disease and high-dose favipiravir. On day 10 of illness, she had acute respiratory distress syndrome, possibly caused by transfusion-related acute lung injury, which was managed without mechanical ventilation. Discharge was delayed because of the detection of viral RNA in several bodily fluids despite clearance of viraemia. The patient was discharged on day 34 of illness. At the time of discharge, the patient had possible subacute post-viral thyroiditis. None of the people who had contact with the patient before and after admission became infected with Ebola virus., Interpretation: This report emphasises the uncertainties about the efficacy of experimental treatments for Ebola virus disease. Clinicians should be aware of the possibility of transfusion-related acute lung injury when using convalescent plasma for the treatment of Ebola virus disease., Funding: La Paz-Carlos III University Hospital., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
16. [Partial trisomy 1q due to maternal translocation].
- Author
-
Campos Tristán C and Fernández Puntero B
- Subjects
- Female, Humans, Infant, Karyotyping, Phenotype, Chromosomes, Human, Pair 1 genetics, Translocation, Genetic genetics, Trisomy genetics
- Published
- 2000
17. Anti-inflammatory and antiulcer activity of Teucrium buxifolium.
- Author
-
Fernández Puntero B, Iglesias Peinado I, and Villar del Fresno AM
- Subjects
- Animals, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Anti-Inflammatory Agents, Non-Steroidal toxicity, Anti-Ulcer Agents administration & dosage, Anti-Ulcer Agents pharmacology, Carrageenan administration & dosage, Carrageenan toxicity, Disease Models, Animal, Edema chemically induced, Female, Gastric Mucosa cytology, Gastric Mucosa drug effects, Indomethacin administration & dosage, Indomethacin toxicity, Mice, Plant Extracts administration & dosage, Plant Extracts chemistry, Plant Extracts pharmacology, Plant Extracts therapeutic use, Plants, Medicinal, Rats, Rats, Wistar, Spain, Stomach Ulcer chemically induced, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Anti-Ulcer Agents therapeutic use, Arthritis, Experimental drug therapy, Edema drug therapy, Stomach Ulcer prevention & control
- Abstract
Teucrium buxifolium Spanish endemic, have traditionally been used for the treatment of rheumatic and other inflammatory affections. In this work, phytochemical screening was carried out to ascertain the qualitative composition of this species and we have studied the anti-inflammatory and antiulcer activity of Teucrium buxifolium. This species has exhibited potent anti-inflammatory properties against experimentally-induced arthritis and carrageenin paw edema. Additionally, Teucrium buxifolium species have displayed significant antiulcer and cytoprotective activity.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.